Adverum Biotechnologies (ADVM) to Offer $100M in Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. SPOT
6. BYD
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Adverum Biotechnologies (ADVM) to Offer $100M in Stock

Adverum Biotechnologies Announces $100 Million Public Offering of Common Stock

February 10, 2020 4:01 PM EST

REDWOOD CITY, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that it has commenced an underwritten public offering of $100 million of its common stock. The company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. All of the shares in the offering will be sold by Adverum Biotechnologies. The offering is subject to market and... More